Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
338 results
  1. Childhood Vascular Tumors Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK343452
    ... also been treated with radiation therapy, chemotherapy, alpha-interferon therapy, and sirolimus.[ 166 - 170 ] References Kilcline C, Frieden IJ: Infantile hemangiomas: how common ...
  2. Interstitial Cystitis | IC | PBS | MedlinePlus 
    https://medlineplus.gov/interstitialcystitis.html
    ... interstitial cystitis/bladder pain syndrome: systematic... Article: Intravesical Interferon Therapy vs Hyaluronic Acid for Pain Among Female Individuals... Interstitial Cystitis -- see more articles Reference Desk Urinary Tract and How It Works (National ...
  3. Chronic Myelogenous Leukemia Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65916
    ... beyond 10 years.[ 10 ] Maintenance of therapy with interferon is required, however, and some patients experience side effects that preclude continued treatment. References Jabbour E, Kantarjian H: Chronic myeloid leukemia: 2012 ...
  4. NLM Digital Collections - Management of hepatitis C : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), July 2013
    resource.nlm.nih.gov/101671095
    ... drug therapies? Consider: Amantadine, thymosin, histamine, long term interferon treatment. | 49 Management of hepatitis C References 16. Henderson D. Managing occupational risks for hepatitis ...
  5. COPD | Chronic Obstructive Pulmonary Disease | MedlinePlus 
    https://medlineplus.gov/copd.html
    ... Chronic Obstructive (National Institutes of Health) Journal Articles References and abstracts from MEDLINE/PubMed (National Library of Medicine) Article: Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of... Article: Phase 1 Study ...
  6. Cost-effectiveness analysis: diagnostic tests and surveillance strategies for cirrhosis - Cirrhosis in Over 16s - NCBI .... 
    https://www.ncbi.nlm.nih.gov/books/NBK385231
    ... procedure and drug costs where relevant. When pegylated interferon was used as a drug treatment a more intensive management is assumed according to current clinical protocols. Staff costs were sourced from the NHS reference cost 2013/14 schedules and PSSRU 2014. A ...
  7. Excluded Studies - Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis - .... 
    https://www.ncbi.nlm.nih.gov/books/NBK294213
    ... for exclusion appears at the end of each reference) 1. Barbero P, Verdun E, Bergui M, et al. High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained ...
  8. NLM Digital Collections - Disease-modifying therapies for relapsing-remitting and primary-progressive multiple ... 
    Publication: Boston, MA : Institute for Clinical and Economic Review, March 6, 2017
    resource.nlm.nih.gov/101704699
    ... Randomized Trials of DMTs for RRMS MS Prior Reference Study Group* N F/U (weeks) Definition Treatment Interferon β-1a 30 mcg (Avonex) Jacobs 199680 - IFN ...
  9. Hairy Cell Leukemia Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65741
    ... of hairy cell infiltration. After the initiation of treatment with cladribine (2-chlorodeoxyadenosine, ... Grever MR, Abdel-Wahab O, Andritsos LA, et ...
  10. Full evidence review - Melanoma - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK338408
    ... most notably the lack of probabilistic sensitivity analysis . References 1. Wilson LS, Reyes CM, Lu C, et al. Modelling the cost-effectiveness of sentinel lymph node mapping and adjuvant interferon treatment for stage II melanoma. Melanoma Research. 2002; 12 ( ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last